切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2013, Vol. 02 ›› Issue (06) : 283 -287. doi: 10.3877/cma.j.issn.2095-3216.2013.06.002

述评

妊娠期急性肾损伤的处理策略
李英1,()   
  1. 1.050081 石家庄,河北医科大学第三医院肾内科河北省肾脏病研究中心
  • 出版日期:2013-12-15
  • 通信作者: 李英

Processing strategy of acute kidney injury in pregnancy

Ying LI1,()   

  1. 1.Department of Nephrology, Third Hospital of Hebei Medical University, Kidney Disease Research Center of Hebei Province, Shijiazhuang 050081, China
  • Published:2013-12-15
  • Corresponding author: Ying LI
引用本文:

李英. 妊娠期急性肾损伤的处理策略[J/OL]. 中华肾病研究电子杂志, 2013, 02(06): 283-287.

Ying LI. Processing strategy of acute kidney injury in pregnancy[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2013, 02(06): 283-287.

急性肾损伤(AKI)是妊娠期的急性并发症,一旦发生母婴死亡率较高,应引起足够的重视。 妊娠期肾脏会发生一系列生理性变化以适应母婴需求,如肾脏体积增大、肾小球滤过率(GFR)增加、高凝状态等,使肾脏较非妊娠者更易受损。 常见的妊娠期AKI 主要有妊娠期相关血栓性微血管病[TMA,如子痫前期(PE);溶血、肝酶升高、血小板减少(HELLP)综合征;血栓性血小板减少性紫癜(TTP);溶血尿毒综合征(HUS)];妊娠期急性脂肪肝(AFLP);急性肾小管坏死(ATN)及急性肾皮质坏死(ARCN)等。 对于重度PE、HELLP 综合征和AFLP,一经诊断,应终止妊娠,而TTP 及HUS 应以血浆置换为主要治疗措施。 对于ATN 及ARCN 导致的妊娠期AKI,应给予祛除病因及支持对症治疗,有指征时可行血液净化疗法。

Acute kidney injury is an acute complication in pregnancy with a high mortality of the maternal and infant once occurs, which should arouse enough attention. There are a series of physiological changes of kidneys in pregnancy to adapt to demands from the maternal and infant, such as kidney volume increase, glomerular filtration rate (GFR) increase, and hypercoagulable state, etc. Therefore, the kidneys in pregnancy were more easily subject to injury than kidneys not in pregnancy. The common causes of acute kidney injury in pregnancy includes pregnancy-related thrombotic microangiopathy [TMA, such as preeclampsia (PE); hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome; thrombotic thrombocytopenic purpura (TTP); and hemolytic uremic syndrome (HUS)]; acute fatty liver in pregnancy(AFLP); acute tubular necrosis (ATN), and acute renal cortical necrosis (ARCN), etc. For severe PE,HELLP syndrome, and AFLP, the pregnancy should be terminated upon diagnosis. while for TTP, and HUS, plasmapheresis should be the main treatment method. For acute kidney injury resulting from ATN or ARCN in pregnancy, both etiological treatment and symptomatic treatment should be given, with blood purification therapy being administered when indicated.

图1 妊娠期各阶段发生急性肾损伤的常见病因
1
Gammill HS, Jeyabalan A. Acute renal failure in pregnancy [J].Crit Care Med,2005,33(10 Suppl): S372-384.
2
Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States [J]. Obstet Gynecol,2009,113(6):1299-1306.
3
Martin JN Jr, Blake PG, Perry KG Jr, et al. The natural history of HELLP syndrome: patterns of disease progression and regression[J]. Am J Obstet Gynecol,1991,164 (6 Pt 1): 1500-1509;discussion 1509-1513.
4
Acharya A, Santos J, Linde B, et al. Acute kidney injury in pregnancy-current status [J]. Adv Chronic Kidney Dis, 2013, 20(3):215-222.
5
Fakhouri F, Vercel C, Fremeaux-Bacchi V. Obstetric nephrology:AKI and thrombotic microangiopathies in pregnancy [J]. Clin J Am Soc Nephrol,2012,7(12):2100-2106.
6
Youssef A, Righetti F, Morano D, et al. Uterine artery Doppler and biochemical markers (PAPP-A, PIGF, sFlt-1, P-selectin, NGAL)at 11 +0 to 13 +6 weeks in the prediction of late ( > 34 weeks)pre-eclampsia [J]. Prenat Diagn,2011,31(12):1141-1146.
7
Adrogue HJ, Madias NE. Management of life-threatening acid-base disorders. First of two parts [J]. N Engl J Med,1998,338(1):26-34.
8
Andres RL, Saade G, Gilstrap LC, et al. Association between umbilical blood gas parameters and neonatal morbidity and death in neonates with pathologic fetal acidemia [J]. Am J Obstet Gynecol,1999,181(4):867-871.
9
Machado S, Figueiredo N, Borges A, et al. Acute kidney injury in pregnancy:a clinical challenge [J]. J Nephrol,2012,25(1):19-30.
10
Al-Safi Z, Imudia AN, Filetti LC, et al. Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications [J]. Obstet Gynecol,2011,118(5):1102-1107.
11
Johnson RJ, Kanbay M, Kang DH, et al. Uric acid: a clinically useful marker to distinguish preeclampsia from gestational hypertension [J]. Hypertension,2011,58(4):548-549.
12
Silasi M, Cohen B, Karumanchi SA, et al. Abnormal placentation,angiogenic factors,and the pathogenesis of preeclampsia[J]. Obstet Gynecol Clin North Am,2010,37(2):239-253.
13
Villa PM, Kajantie E, Raikkonen K, et al. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials [J]. BJOG,2013,120(1):64-74.
14
Publications Committee SfM-FM, Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks' gestation [J]Am J Obstet Gynecol,2011,205(3):191-198.
15
Townsley DM. Hematologic complications of pregnancy [J]. Semin Hematol,2013,50(3):222-231.
16
George JN. How I treat patients with thrombotic thrombocytopenic purpura:2010 [J]. Blood,2010,116(20):4060-4069.
17
Scully M,Hunt BJ,Benjamin S,et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies [J]. Br J Haematol,2012,158(3):323-335.
18
Gall B, Yee A, Berry B, et al. Rituximab for management of refractory pregnancy-associated immune thrombocytopenic purpura[J]. J Obstet Gynaecol Can,2010,32(12):1167-1171.
19
Vesely SK, Li X, McMinn JR, et al. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome [J]. Transfusion,2004,44(8):1149-1158.
20
Skerka C,Jozsi M,Zipfel PF,et al. Autoantibodies in haemolytic uraemic syndrome (HUS) [J]. Thromb Haemost,2009,101(2):227-232.
21
Woodruff TM, Nandakumar KS, Tedesco F. Inhibiting the C5-C5a receptor axis [J]. Mol Immunol,2011,48(14):1631-1642.
22
Kelly R, Arnold L, Richards S, et al. The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab [J]. Br J Haematol,2010,149(3):446-450.
23
Knight M, Nelson-Piercy C, Kurinczuk JJ, et al. A prospective national study of acute fatty liver of pregnancy in the UK [J]. Gut,2008,57(7):951-956.
24
Lee NM, Brady CW. Liver disease in pregnancy [J]. World J Gastroenterol,2009,15(8):897-906.
25
Podymow T, August P, Akbari A. Management of renal disease in pregnancy [J]. Obstet Gynecol Clin North Am, 2010, 37(2):195-210.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 曹琮沅, 黄烁金, 何倩婷, 王安训. 平阳霉素复合剂治疗口腔颌面部脉管畸形的有效性和安全性[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 368-374.
[3] 严华悦, 刘子祥, 周少波. 磷酸烯醇式丙酮酸羧激酶-1在恶性肿瘤中的研究进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 452-456.
[4] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[5] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[6] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[7] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[8] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[9] 石海波, 赵旭东, 王聪, 曲巍. 气肿性肾盂肾炎、气肿性膀胱炎并脓毒性休克一例报道并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 644-647.
[10] 林逸, 钟文龙, 李锴文, 何旺, 林天歆. 广东省医学会泌尿外科疑难病例多学科会诊(第15期)——转移性膀胱癌的综合治疗[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 648-652.
[11] 王秋生. 胆道良性疾病诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 779-782.
[12] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[13] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[14] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[15] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
阅读次数
全文


摘要